Anavex Existence Sciences qualifies to trade on OTCQX OTC Markets Group Inc. , operator of Open, Linked and Transparent economic marketplaces, announced that Anavex Life Sciences Corp today headache . Anavex starts trading today on OTCQX beneath the symbol ‘AVXL.’ U.S. Investors can find current financial disclosure and Real-Time Level 2 rates for the ongoing business on Related StoriesMeat-rich diet may boost kidney cancers riskFDA grants accelerated authorization for Tagrisso to treat patients with advanced NSCLCEight myths and truths about Alzheimer's disease’We are pleased to welcome Anavex to the OTCQX industry,’ said R. Cromwell Coulson, President and CEO of OTC Markets Group. ‘Growing U.S. Businesses like Anavex choose OTCQX to show transparency and boost their engagement and presence with U.S. Investors. We look forward to working with Anavex's management team as the company is growing and expand its presence in the U.S. Market.’ ‘We are delighted that Anavex has been authorized for trading on the OTCQX market,’ stated Christopher U. Missling, PhD, Chief and President Executive Officer for Anavex. ‘As well as our development milestones, like the latest commencement of a Stage 2a trial for our Alzheimer's compound ANAVEX 2-73 and drug combination ANAVEX PLUS, the increased presence and transparency of the OTCQX marketplace has the potential to help increase the liquidity for our stock and improve shareholder value over the future.’ K&L Gates LLP serves as Anavex's Designated Advisor for Disclosure on OTCQX, in charge of providing professional help with OTCQX requirements and U.S. Securities laws. Related StoriesPhysicians leave severe acne individuals on ineffective antibiotics for too much time before prescribing stronger drugArchbishop of York agrees to become Antibiotic Research UK's PatronShared decision building between doctors and sufferers useful in fight antibiotic resistance’Specialists had long predicted this on theoretical grounds, but they say the brand new finding underlines the necessity to make use of antibiotics sparingly, given that the genes for antibiotic level of resistance are ubiquitous and will easily be promoted by antibiotics,’ the newspaper writes, adding that the finding ‘underlines the threat of looking at bacteria from a purely medical perspective. Resistance to antibiotics is usually a defense that bacteria have developed within an arms race that has eliminated on for a billion years’ . This content was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an independent news service editorially, is a scheduled system of the Kaiser Family members Foundation, a nonpartisan health care policy research company unaffiliated with Kaiser Permanente.